Systematic Reviews
Copyright ©The Author(s) 2020.
World J Cardiol. Jun 26, 2020; 12(6): 269-284
Published online Jun 26, 2020. doi: 10.4330/wjc.v12.i6.269
Table 2 List of studies reported the incidence rate of ventricular arrhythmia during right heart catheterization
YearNumber RHCTypes of arrhythmiaIncidence rate, n (%)SettingStudy designProcedural OutcomesRef.
197973VA (> 1 PVCs in 4 beats)27 (36.9)ORProspectiveAll self-limitedShaw et al[58]
Randomized
1981320Overall36 (16.4)ICUProspective3 VTs: TreatmentSise et al[20]
VA not treatment33 (10)Observational
VA required treatment3 (1)
198160PVCs29 (48)ICURetrospective2 VTs: TreatmentSprung et al[56]
VT20 (33)Observational1 VF: Mortality
1982107VT (> 3 cPVCs, > 150 pbm)ORProspectiveAll self-limitedSalmenpera et al[60]
Lidocaine8/53 (15)Randomized
Placebo10/54 (19)
1982150Advanced VA80 (53)ICUProspective3 VTs: TreatmentSprung et al[17,56]
Salvos (3-5 cPVCs)45 (30)Observational2 VFs: Mortality
NSVT (6-30 cPVCs)30 (20)
VT (> 30 cPVCs)5 (3)
VF2 (1.3)
198367Advanced VA42 (63)ICUProspectiveAll self-limitedSprung et al[59]
Lidocaine ppx18/31 (58)Randomized
placebo24/36 (67)
1983528PVCs58 (11)ICUProspective8 VTs: MedsBoyd et al[21]
VT8 (1.5)Observational
VF0
198556Advanced VA7 (12.5)ICUProspectiveAll self-limitedIberti et al[22]
Observational
1985250PVCs162/250 (64.8)ORProspectiveAll self-limitedDamen et al[14]
VT (> 3 cPVC > 100 bpm)11/250 (4.4)Observational
VF0
19861400Overall880/1400 (62.9)ORProspectiveAll self-limitedDamen et al[2]
PVCs838/1400 (59.9)Observational
VT (> 3 cPVC > 100 bpm)42/1400 (3)
VF0
1986142Overall64 (45)ICUProspectiveAll self-limitedPatel et al[55]
Benign (singlet PVCs)24 (16.9)Observational
Malignant140 (28.1)
198968Overall55 (80.9)ORProspectiveAll self-limitedKeusch et al[57]
Benign (1-2 PVCs)30 (44.1)Observational
Malignant225 (36.8)
2007100PAC insertionORProspectiveAll self-limitedGwak et al[13]
Overall70 (70)Observational
Benign33 (33)
Malignant337 (37)
2012139Overall76/139 (54.7)ORProspectiveAll self-limitedPipanmekaporn et al[28]
Benign (1-2 PVCs)58 (41.7)Randomized
Severe (≥ 3 PVCs)28 (20.1)
2013380VT0Hybrid CCLRetrospectiveDCCVBergmann et al[19]
VF1 (0.26)Observational
2017174Overall149/174 (85.6)ORProspectiveAll self-limitedSatol et al[23]
Multiple PVCs ≥ 278/174 (44.8)Observational